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Activation-induced cytidine deaminase (AID) is a B cell enzyme
essential for Ig somatic hypermutation and class switch recombi-
nation. AID acts on ssDNA, and switch regions of Ig genes, a target
of AID, form R-loops that contain ssDNA. Nevertheless, how AID
action is specifically targeted to particular DNA sequences is not
clear. Because mutations altering cotranscriptional messenger ri-
bonucleoprotein (mRNP) formation such as those in THO/TREX in
yeast promote R-loops, we investigated whether the cotranscrip-
tional assembly of mRNPs could affect AID targeting. Here we
show that AID action is transcription-dependent in yeast and that
strong and transcription-dependent hypermutation and hyperre-
combination are induced by AID if cells are deprived of THO. In
these strains AID-induced mutations occurred preferentially at
WRC motifs in the nontranscribed DNA strand. We propose that a
suboptimal cotranscriptional mRNP assembly at particular DNA
regions could play an important role in Ig diversification and
genome dynamics.
hyperrecombination  hypermutation  messenger ribonucleoprotein
biogenesis  R-loops
Activation-induced cytidine deaminase (AID) is a specific Bcell enzyme believed to be responsible for the initiation of
somatic hypermutation (SHM) and class switch recombination
(CSR) during B cell differentiation (1–3). Many studies have
shown that AID acts directly on DNA (4), the natural target for
AID action in the variable and switch (S) regions for SHM and
CSR, respectively. The specific mechanisms of AID function are
still unclear, but evidence suggests that the preferential target of
AID may be ssDNA (5, 6). Thus, in vitro experiments have shown
that AID deaminates ssDNA and dsDNA that is transcribed
(5–7), and transcription has been shown to be required for both
SHM and CSR in vivo (8, 9).
Studies have shown a strand preference for the action of AID
during in vitro transcription with AID-induced mutations de-
tected preferentially in the nontranscribed (NT) strand (6,
10–12). Analysis of the products of SHM in B cells, however,
reveals that both DNA strands are mutated (13). Other in vitro
studies have shown that AID can deaminate both strands within
regions of supercoiled DNA (14) and that the ssDNA-binding
replication protein A is required for deamination of SHM targets
(15). All of these findings are consistent with the idea that
transient formation of ssDNA during transcription facilitates
AID action.
Along the same line, formation of R-loops during transcrip-
tion of the S regions has been proposed (16). Such R-loops would
possibly provide AID with ssDNA substrates at its target region
because there the transcribed (T) strand hybridizes with the
nascent RNA and the NT strand is present as ssDNA. Because
of its high G content, the NT DNA strand at S regions could be
stabilized by the formation of parallel four-stranded G quartets
(17, 18). Indeed, AID appears to bind specifically to G-loops
within transcribed S regions (19) and can deaminate the dis-
placed strand of a transcription-induced R-loop in vitro (20).
Interestingly, cotranscriptional messenger ribonucleoprotein
(mRNP) biogenesis is an essential step in gene expression that
may influence genetic integrity (21, 22). In the yeast Saccharo-
myces cerevisiae, hyperrecombination can be triggered by tran-
scription in mutants depleted of THO/TREX, a conserved
protein complex that functions at the interface between tran-
scription and mRNA export (23, 24). THO is a conserved
complex first identified in yeast and formed by Tho2, Hpr1,
Mft1, and Thp2 (24). It interacts with the Sub2 RNA-dependent
ATPase and the Yra1 RNA-binding protein to form the TREX
complex (23). THO has been shown to be required for the
transcription of long genes and genes containing either high GC
content or multiple internal repeats (25, 26). It is believed that
THO controls the cotranscriptional formation of export-
competent mRNP during transcription elongation by controlling
the assembly of heterogeneous nuclear ribonucleoproteins onto
the nascent mRNA (21). Hyperrecombination of THO mutants
is particularly evident in long and GC-rich DNA sequences such
as the bacterial lacZ gene (26). Because hyperrecombination
depends on the formation of DNA:RNA hybrids (22), it has been
proposed that one function of THO/TREX is to prevent the
nascent mRNA from interacting with the template DNA to form
R-loops. The observation that the ASF/SF2 splicing factor has a
similar role in chicken DT40 and HeLa cells (27) suggests that
a number of RNA processing enzymes have an additional role in
preventing R-loop formation.
One important and unresolved question is why AID is targeted
at specific DNA regions during B cell differentiation, and we
wondered whether this could be because of suboptimal mRNP
formation. To test this possibility, we confirmed that AID can
induce hypermutation and hyperrecombination at low levels in
yeast cells (28, 29) and demonstrated additionally that this
instability occurs in a transcription-dependent manner. Using
yeast THO mutants as a way to generate suboptimal mRNP
formation, we found that both hypermutation and hyperrecom-
bination were strongly and synergistically increased in a
transcription-dependent manner, with mutations primarily oc-
curring in the NT strand. We propose that a suboptimal co-
transcriptional mRNP assembly at particular DNA regions can
regulate AID action, and we suggest that the control of mRNP
biogenesis may play an important role in Ig diversification and
genome dynamics.
Results
Mutations in the THO Complex Confer a Slight Transcription-
Dependent Hypermutation Phenotype. Because THO mutants
share phenotypes of recombination-mediated genetic instability
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associated with transcription, it was important to know whether
they showed, in addition to hyperrecombination, a transcription-
dependent hypermutation phenotype. Two different plasmid-
borne assays were developed for the analysis of forward muta-
tions. The first assay is based on a fusion of the KAR1 ORF to
the regulated GAL1 promoter (GKAR1 system). Because KAR1
overexpression is lethal in yeast (30), kar1 mutations can be
selected on galactose medium. The second assay is based on a
lacZ::URA3 translational fusion under control of the regulated
Tet promoter (LAUR system) (31). In this assay, Ura mutants
are selected on synthetic complete (SC) medium supplemented
with 5-fluoroorotic acid, whereas lacZ mutants and lacZ are
scored by color on SC plus X-Gal. As can be seen in Fig. 1 A and
B, the mutation frequencies were increased 13-fold when tran-
scription was high in both systems. Transcription-associated
mutation (TAM) was also observed in rad52 cells although to
a minor extent (Fig. 1B). The result is in agreement with previous
reports indicating that transcription increases mutation in yeast
cells (32) and Escherichia coli (reviewed in ref. 33).
Next, we used both the LAUR and GKAR1 assays to deter-
mine whether different THO mutations stimulated TAM. As
seen in Fig. 1A, mft1 and hpr1, which caused an elimination
of the THO complex in yeast cells (34), increased the frequency
of mutation 2- to 3-fold in GKAR1 at low transcription versus 38-
to 60-fold at high transcription levels. Similarly, in the LAUR
system, the increase in mutation frequency was significantly
stronger for high transcription (96- to 189-fold) than for low
transcription (2- to 17-fold) as assayed in both the mft1 and
hpr1 backgrounds (Fig. 1B). Therefore, THO mutants share a
transcription-dependent hypermutation phenotype that is not as
strong as its hyperrecombination phenotype observed in several
direct-repeat assays (26). Because all null mutations of the genes
encoding the different THO subunits lead to deprivation of
THO (34) and the same phenotypes (24), we decided to continue
our analysis with mft1, which, in contrast to hpr1, has little
impact on growth.
To gain insight into the molecular basis of mutations caused
by THO mutations, we performed a genetic analysis of the
pattern of mutations caused by mft1. As expected from the fact
that transcription through lacZ is the most sensitive step in THO
mutants (26), every Ura mutant was also lacZ in all conditions
tested, implying that all mutations mapped within lacZ (54 in
high transcription and four in low transcription) (Fig. 2),
whereas, in the wild type, 34–40% of the Ura mutations were
lacZ (lacZ:lacZ ratios of 50:32 and 80:41 in low and high
transcription, respectively) (Fig. 2); that is, they occurred within
URA3. The mft1 mutations must, therefore, be either frame-
shifts or premature stop codons within lacZ or DNA rearrange-
ments covering lacZ and URA3. Given the strong transcription-
dependent hyperrecombination phenotype of THO mutants, it
was important to determine whether lacZ Ura colonies in the
mft1 background arose by recombination-dependent rear-
rangements, which are known to be Rad52-dependent. The
spontaneous mutation frequency under high transcription in the
rad52 strain was 2-fold lower than in the wild type (Fig. 1B),
although it has been reported that TAM increases in rad52 cells
(32, 35), indicating that some of the TAM events observed in the
wild type may arise by a Rad52-dependent pathway in the LAUR
construct. The rad52mutation causes a decline in the mutation
frequency of mft1 cells of 6.5-fold (from 2.9  105 to 4.5 
106), indicating that most of TAM events in mft1 occur by
RAD52-dependent rearrangements rather than by point muta-
tions (Fig. 1B). In contrast to wild-type cells in which none of
eight analyzed Ura mutants contained detectable rearrange-
ments, 62% of the mutants (23 of 37) contained rearrangements
in mft1 [supporting information (SI) Fig. 5]. Thus, the absence
of THO stimulates Rad52-independent mutations 2- to 3-fold
(from 0.6 106 to 1.2 106 and from 1.5 106 to 4.5 106
in low and high transcription, respectively) (Fig. 1B). Indeed,
Fig. 1. Effect of transcription and AID on the frequency of mutation in S.
cerevisiae wild-type and THO mutant strains. (A) Frequency of Kar mutants
obtained in the GKAR1 system. (B) Frequency of Uramutants obtained in the
LAUR system and Rad52 dependency. (C) Effect of AID on the frequency of
Ura mutants in the LAUR system in wild-type, mft1, rad52, and mft1
rad52 strains. All experiments were performed under high (ON) and low
(OFF) transcription. Diagrams of systems are shown above each graph. Mean
mutation frequency and standard deviation of three to four different fluctu-
ation tests are plotted.
Fig. 2. Genetic analysis of spontaneous (AID) and AID-induced (AID)
mutations. Distribution of lacZ:lacZ mutations among Ura mutants in
wild-type and mft1 strains is shown. An asterisk indicates a statistically
significant difference (P 0.05) with respect to the wild-type value under the
same transcription conditions, as determined by contingency 2 analysis.
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50% of Ura mutations are lacZ in the mft1 rad52 mutant
(7:7 lacZ:lacZ ratio; data not shown), consistent with the
conclusion that THO mutants also stimulate point mutations,
although slightly, in a transcription-dependent manner.
AID-Induced Mutation Is Transcription-Dependent in Yeast. Taking
advantage of the LAUR assay, we studied the ability of AID to
induce mutation and whether this ability depended on transcrip-
tion in wild-type cells. As can be seen in Fig. 1 B and C, AID
expression in wild-type yeast did not lead to hypermutation at
low transcription, but caused a 2-fold increase at high transcrip-
tion (from 3.9  106 to 7.6  106). Consistent with a lack of
an AID effect on mutation frequency under low transcription in
the wild type, the ratio of lacZ:lacZ among Ura mutants was
similar regardless of whether cells expressed AID (11:9 versus
50:32) (Fig. 2). However, a significant change (P  0.05) in this
ratio was observed under high transcription if AID was ex-
pressed (66:86 versus 80:41), indicating that the pattern of
mutations was changed by AID in a transcription-dependent
manner. Therefore, AID induces a weak transcriptional-
dependent increase in the frequency of mutation and a change
in the pattern of mutations.
AID-InducedMutation Is Strongly Stimulated by THOMutations.THO
mutations may create local regions that are susceptible to
forming recombinogenic and mutagenic intermediates in a
transcription-dependent manner. To determine whether such
regions would be more susceptible to AID action, we tested the
effect of AID on the frequency and pattern of mutations in
mft1 cells. As can be seen in Fig. 1C, in mft1 cells the effect
of AID on the frequency of mutations was greater than in the
wild type, leading to a 13-fold increase in mutations at low
transcription that went up to 630-fold at high transcription (Fig.
1C). Under low and high transcription, AID stimulated the
mutation frequency 6.5 times (from 0.6 106 to 3.9 106 and
from 2.9  105 to 1.9  104, respectively) in mft1 cells.
Importantly, this hypermutator effect of AID was not dependent
on Rad52. AID expression further increased Ura mutations
81-fold (from 4.5  106 to 3.7  104) in mft1 rad52 cells
under high transcription (Fig. 1 B and C), indicating that they are
not due to rearrangements but most likely point mutations.
THO mutations enhance AID action presumably by creating
a local structure in the transcribed DNA region that works as a
target for AID. Therefore, we would expect that nonframeshift
point mutations mapping at lacZ and conferring a lacZ but not
Ura phenotype would occur at a high frequency in mft1 but
not in wild-type cells expressing AID. As expected, we were not
able to detect lacZ Ura mutants from 5,922 colonies in
wild-type cells expressing AID (frequency 103), whereas in
mft1 expressing AID we counted 47 lacZ Ura mutants of
4,692 colonies (frequency of 1  102) (SI Table 2). This result
indicates that the frequency of Ura AID-induced mutations in
mft1 was underestimated in the LAUR system and indicates a
strong effect of THO mutations on AID action. Therefore,
transcription and AID result in a strong hypermutator pheno-
type in mft1 cells.
AID Mutates Preferentially the NT Strand in mft1 but Shows No
Strand Preference in theWild Type.AID acts preferentially at WRC
(GYW in the opposite strand) motifs (11) that are part of the
WRCY motifs (RGYW in the opposite strand) found as hotspots
of SHM (36) (where W is A or T, R is A or G, and Y is C or T).
As R-loops in THO mutants (19) leave ssDNA opposite the
DNA:RNA hybrid, one prediction is that most of the AID-
induced mutations in mft1 cells should be at WRC motifs and
in the NT strand. Therefore, we sequenced spontaneous and
AID-induced mutations in wild-type and mft1 cells. As shown
in Fig. 2, all mutants in mft1 cells were lacZ Ura, which can
be explained if the Ura phenotype results from frameshift
mutations, stop codons, or rearrangements occurring at lacZ.
This view is consistent with the fact that transcription through
lacZ is the most sensitive step in THO mutants (26). Therefore,
because point mutations at URA3 are not detected and lacZ
Ura mutants represent a biased class of mutations at lacZ, we
decided to sequence the lacZ sequence of the lacZ Ura
mutants that arose in mft1 cells expressing AID under high
transcription conditions. The URA3 ORF from 19 and 53
independent lacZ Ura mutants obtained from the wild type
with and without AID overexpression, respectively, was also
sequenced (SI Fig. 6 A and B). Results are summarized in Table
1 and SI Table 3. In wild-type cells not expressing AID 60%
(11 of 19) were point mutations and only 9% of these (1 of 11)
were within the WRC/GYW target motif of AID. In contrast, in
the wild type and mft1 expressing AID, the percentage of point
mutations increased to 86% (46 of 53) and 91% (22 of 24),
respectively. Of these, 65% (30 of 46) and 54% (12 of 22),
respectively, occurred at the WRC/GYW motif. Altogether, the
data indicate that AID has a preferential function as a cytosine
deaminase at the WRC/GYW motif, consistent with the pref-
erential target of AID deamination observed in vitro (11).
As AID deaminates C within ssDNA, mutations occurring at
C should reflect the action of AID directly on the NT strand,
whereas mutations at G reflect the action of AID on C in the T
strand. Therefore, we analyzed the NT:T ratio of AID-induced
mutations in both strains. Whereas in the wild type expressing
AID the NT:T ratio of mutations was 0.75:1 (16:21), this ratio
increased significantly (P  0.05) to 3:1 (16:5) in mft1. Impor-
tantly, from these mutations, the WRC AID-target motif was
mutated at an NT:T ratio of 1:1 in the wild type (15:15) and 5:1
in mft1 (10:2). The lack of strand preference of the mutation
pattern produced by AID in the wild type was not observed
previously (29) and is consistent with the transient opening of
DNA strands by transcription presumably promoted by negative
supercoiling. By contrast, the putative impairment of mRNP
biogenesis caused by mft1 promotes a more stable formation of
ssDNA on the NT strand and makes it an appropriate target for
the action of human AID. The transversions:transitions ratio
also decreased from 11:0 in the wild type to 35:11 and 13:9 in
wild-type and mft1 cells expressing AID, respectively (Table 1).
The increase in transitions is consistent with the direct action of
AID in deaminating C to U, which leads to a C-to-T transition
(G to A in the opposite strand). Consistently, the changes
produced by AID were more evident for C (or G) with a strong
bias for C in mft1 cells (Table 1).
AID-Induced Recombination Is Transcription-Dependent and Strongly
Stimulated by THO Mutations in Yeast Cells. Finally, AID has also
been shown to contribute to recombination in yeast (28, 29). This
increase reflects the ability of AID to, in a direct or an indirect
Table 1. Spontaneous (AID) and AID-induced (AID) base
substitutions in the wild type (lacZ Ura) and mft1 mutants
(lacZ Ura) classified according to different sequence features
Sequence features WT WT  AID mft1  AID
Mutations at C 0 16 16
Mutations at G 7 21 5
Mutations at WRC 0 15 10
Mutations at GYW 1 15 2
Transversions 11 35 13
Transitions 0 11 9
Point mutations 11 46 22
Total mutations 19 53 24
DNA sequences are shown in SI Fig. 6 A and B.






way, induce the formation of DNA double-strand breaks, which
in yeast are preferentially repaired by recombination, whereas in
human cells they are repaired by nonhomologous end-joining.
Indeed nonhomologous end-joining is believed to be the major
mechanism that leads to class switching in B cells (see ref. 37).
We expected that AID should also increase recombination in a
transcription-dependent manner in wild-type yeast and much
more strongly in mft1. For this purpose we used a plasmid–
chromosome recombination assay between a CEN-plasmid
leu2-r under control of the regulated Tet promoter and a
chromosomal leu2-k mutation (38) in the wild type. As seen in
Fig. 3A, AID did not change the frequency of gene conversion
of leu2-r at low transcription. However, it caused a 40-fold
increase at high transcription. Thus, like the mutagenic activity,
the hyperrecombinogenic activity of AID is transcription-
dependent in yeast. These findings are consistent with the view
that both AID-induced mutation and recombination are the
output products of a common intermediate.
Because direct-repeat recombinants are the type of event
primarily increased by THO mutations (24), a direct-repeat
recombination assay was developed for the analysis of deletions
to assess whether THO mutations also strengthen AID-induced
recombination. The assay is based on two truncated GFP
repeats, which are under control of the GAL1 promoter and
interrupted by a lacZ sequence. GFP recombinants are scored
directly by FACS. As shown in Fig. 3B, mft1 and AID inde-
pendently produced a 6-fold increase in GFP deletions,
whereas the combination of mft1 and AID expression caused
a strong synergistic 100-fold increase. Therefore, we conclude
that impairment of mRNP formation caused by THO mutations
enhances the action of AID in a transcription-dependent man-
ner, resulting in a strong induction of both point mutations and
direct-repeat recombination.
Discussion
In this work we show that AID can function in yeast THO
mutants similar to that in human B cells. In wild-type yeast not
only can AID induce hypermutation and hyperrecombination, as
it was previously shown, but, importantly, this induction depends
on transcription. We show that such transcription-dependent
hypermutation and hyperrecombination effects are weak in the
wild type but strongly and synergistically enhanced in mutants of
the THO complex. The synergistic effect of AID and THO
mutations is also demonstrated at the molecular level by showing
that most AID mutations occurred preferentially on the NT
DNA strand. Because THO mutants are affected in mRNP
biogenesis (21, 39), our results suggest that AID action can be
enhanced by suboptimal mRNP formation. These results open
the possibility that a suboptimal formation of the mRNP would
enhance the probability of the nascent mRNA to form a
DNA:RNA hybrid, leaving the NT strand as single-stranded.
Such a single-stranded region would be stabilized by the G-loops
in S regions, so that the final structure promotes AID targeting
(Fig. 4).
For this study we first characterized new in vivo assays for the
analysis of forward mutations under the control of transcription-
Fig. 3. Effect of AID on transcription-associated recombination. (A) Spon-
taneous (AID) and AID-induced (AID) frequency of gene conversion under
high (ON) and low (OFF) transcription between a plasmid leu2-r and a chro-
mosomal leu2-k allele in a wild-type strain. (B) Effect of AID expression on
direct-repeat recombination in the GLG system. The frequency of GFP re-
combinants (signals inside the box) is indicated. y axis, green fluorescence
(FL1H); x axis, unspecific fluorescence (FL2H). A diagram of each system is
shown on the top of each panel.
Fig. 4. A model to explain stimulation of genome instability by AID in yeast
THO mutants compared with the S regions in B cells. (A) Transcription and
mRNP formation mediated by THO in wild-type and THO-depleted yeast cells.
In wild-type yeast, AID is able to act on the DNA when it is transcribed.
Negative supercoiling behind the elongating RNA polymerase II (RNAPII)
allows a weak AID action. In THO-depleted yeast, a cotranscriptional R-loop
can be formed, allowing AID to act on the nontranscribed ssDNA, causing
strong hypermutation and hyperrecombination. (B) A putative example of
transcription and mRNP formation in the S region of Ig genes in human B cells.
The G-rich S region could be refractory to a number of RNA-binding proteins,
therefore forming a suboptimal mRNP at that particular region. Nascent RNA
S regions could lead to local cotranscriptional R-loops or G-loops that would
allow AID action.
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regulated promoters in yeast, with which we have been able to
show that transcription significantly enhances mutation, consis-
tent with a previous result (32), in which this stimulation was
accompanied by a change in the mutation spectrum (40). TAM
has also been shown in bacteria with both spontaneous and
damage-induced mutations (reviewed in ref. 33).
Mutants of the THO complex have a strong transcription-
dependent hyperrecombination phenotype, as shown in direct-
repeat systems (41, 42). Although recombination is also en-
hanced by transcription, the mechanisms underlying
transcription-associated recombination may be different from
those of TAM. Thus, impairment of replication progression by
transcription may be a critical factor triggering transcription-
associated recombination (43, 44), but this is not obvious for
TAM. Our study reveals that THO mutations lead to a low
hypermutator phenotype in the LAUR system, which is based on
a highly expressed lacZ gene (Fig. 1). It is important to note that
the gene expression defect and hyperrecombination phenotypes
of THO mutants have been shown to be particularly strong at
GC-rich DNA sequences such as lacZ (26). The mft1-induced
mutations have a clearly different pattern from those obtained
in wild-type cells. In mft1 cells all mutations occurred within
the lacZ gene of the lacZ::URA3 fusion, whereas in the wild type
40% of the mutations occurred at URA3. Interestingly, muta-
tions originate at the same DNA region, lacZ, where hyperre-
combination is strongly stimulated (41). Indeed, hypermutation
associated with THO mutations is partially dependent on Rad52,
and part of the hypermutation events observed in the LAUR
assay are caused by Rad52-dependent DNA rearrangements (see
Fig. 1B), therefore being a consequence of the strong hyperre-
combination phenotype of these mutants. This result indicates
that the recombinogenic structures generated in THO mutants
may not be mutagenic by themselves.
Our study provides an appropriate system for the analysis of
hypermutation caused by AID. In vitro and in vivo experiments
in E. coli have shown the transcription dependency of AID
deamination and hypermutation, respectively (5–8, 12). A hy-
perrecombination and hypermutation effect of AID was also
observed in yeast (28), but whether this was transcription-
dependent was not determined. In this work we show that
hypermutation and hyperrecombination caused by AID in yeast
are also transcription-dependent, confirming the hypothesis that
the action of AID requires transcription of the target sequence
(4, 6, 12). This is shown not only by an increase in the frequency
of mutations but by the fact that most of these mutations occur
at the AID-preferred DNA motif WRC (see Table 1). Impor-
tantly, the AID effect observed in yeast is still low, which
suggests that there must be additional factors in human B cells
responsible for the specific action of AID on its target DNA
sequences. Indeed, our mutation spectrum analysis did not
reveal a substantial number of A-T mutations (SI Table 3), which
typically compose half of the mutational spectrum of SHM (13),
consistent with the view that additional factors (e.g., mismatch
repair, error-prone polymerases, chromatin structure, etc.) are
regulated in B cells to mediate SHM (45).
The slight AID action observed in wild-type yeast may be
explained by the prediction that the negatively supercoiled DNA
putatively accumulated behind an elongating RNA polymerase
can promote transient formation of ssDNA (14, 46), which is the
preferential target of AID (5, 6). The results indicating that
AID-induced mutations in wild-type yeast occurred at a 1:1 ratio
in the NT:T strands would be consistent with this view, implying
that both strands have equal probability of becoming single-
stranded and, therefore, to be accessed by AID. Previous data
in yeast have revealed a different NT:T strand ratio of mutations
in the CAN1 gene (29). It is likely, therefore, that the pattern of
mutations caused by AID in yeast may not be unique but
dependent on a number of parameters that can include nucle-
otide sequence, chromatin structure, levels of expression, etc.
Further investigations using different genes as mutation targets
may be required to obtain a more complete view of AID action
in yeast. Nevertheless, our results clearly show that a high impact
of AID action in yeast is observed only when mRNP biogenesis
is compromised by THO mutations. We detected a 5:1 bias in
favor of the NT strand, a result that can be explained only if a
more stable nontranscribed ssDNA structure is formed and
simultaneously the T strand is protected from AID action.
Because THO mutations have previously been shown to induce
cotranscriptional R-loop formation, as determined in the same
GC-rich lacZ gene used in this study (22), and S regions also form
R-loops (16), formation of R-loops may be a natural way of
stabilizing ssDNA for AID activity and of protecting the T strand
in the form of the DNA:RNA hybrid. Our data in yeast show,
therefore, that the strong AID effect on hypermutation in
different THO-depleted yeast cells is consistent with the for-
mation of R-loops during transcription (22, 34). Interestingly,
recent reports have shown that AID interacts in vitro with the
elongation complex (47). Because RNA polymerase II progres-
sion is reduced in THO mutants (23), we cannot discard that, in
addition, AID action in THO mutants could be strengthened by
a longer time in which AID could interact with the elongation
complex, therefore increasing its time to act on DNA.
AID deamination seems to trigger the intermediates leading
to class switch recombination in B cells, and some evidence
suggests that class switching occurs by nonhomologous end-
joining (37). Consequently, it is believed that AID deamination
is the first event of a process ending in double-strand breaks.
Whether this putative double-strand break is performed directly
by AID or is formed after replication is a question yet to be
addressed. Because double-strand breaks in yeast are preferen-
tially repaired by recombination, it was expected that AID would
affect recombination similarly to mutation. It was previously
reported that AID induces recombination in yeast (28, 29). In
this study we show that AID is able to increase the frequency of
gene conversion only under high transcription (Fig. 3A), and,
using a direct-repeat recombination assay, which allows us to
detect hyperrecombination in THO mutants, we have been able
to see a strong and synergistic effect of AID and THO mutations
on recombination (Fig. 3B). Therefore, in yeast cells THO
mutations enhance the transcription-dependent AID effect,
whether detected as hypermutation or hyperrecombination.
In summary, our data clearly show that yeast THO mutants
can be used as a model in vivo system for the study of AID action.
Not only are hyperrecombination and hypermutation observed
as a consequence of AID, but they occur in a transcription-
dependent manner. More importantly, the pattern of mutations
fits the previously shown pattern caused by AID in vitro (11),
mutations occurring preferentially at the WRC motif. However,
the pattern observed in vitro, in which mutations are preferen-
tially found at the NT strand (6, 11, 29), is seen only in THO
mutants. Therefore, our results open the possibility that mRNP
biogenesis controlled AID action. It would be interesting to
know whether the high G content of the S-region mRNA in B
cells might limit its capacity to be assembled in an optimal
mRNP, as THO mutations in general do in yeast, thereby
increasing the reactivity of the nascent RNA with the DNA
template (see Fig. 4). Yeast THO mutants can, therefore, be an
excellent tool in deciphering the molecular mechanisms by which
AID can induce both hypermutation and hyperrecombination.
Materials and Methods
Strains and Plasmids. We used W303–1A isogenic strains
WMK-2A (mft1::KAN), U678-1C (hpr1::HIS3), WRS52-4B
(rad52::KAN) [described previously (24)], WMR52-1D and
WMR52-4D (rad52KAN mft1::KAN) (obtained in this study),
and the BY derivative BER08-64A (his3::leu2-k) (38).






Centromeric plasmids pMR260 (30) carrying KAR1 under
control of the GAL1 promoter, pCM184-LAUR (31) containing
lacZ::URA3 under the tet promoter, and pCM184-L2HOr used
for the plasmid–chromosome recombination assay (38) were
described previously. Centromeric plasmids p414GALAID and
p413GALAID carrying the human AID ORF under the GAL1
promoter were obtained by PCR amplification of AID from
pGAID (6) using primers 5-CTCTGGACGAAATTCCATG-
GACAGCCTCTTC-3 and 5-CCTGGAAGCTCGAGT-
CAAAGCTCCAAAGTA-3 and cloning into the EcoRI-XhoI-
digested pRS414GAL and pRS413GAL (38), respectively.
Centromeric plasmid pGLG containing the GFP direct-repeat
construct was obtained by amplifying GFP3 and GFP5




CTCCCAATTTTGGTTGAAT-3 and subcloning into the
SpeI-XbaI and ApaI-SalI sites of pRS413GAL, respectively. The
lacZ ORF was subcloned at a BamHI between the GFP repeats.
Mutation and Recombination Analysis. For the GKAR1 mutation
assay, cells were cultured overnight in SC medium containing 2%
glycerol-lactate as a carbon source. Afterward, the culture was
split in two, one with 2% glucose (transcription OFF) and the
other with 2% galactose (transcription ON), and cultured for
another 9 h before mutant selection. For the LAUR mutation
assay and the plasmid–chromosome recombination assay cells
were cultured in SC plates with (transcription OFF) or without
(transcription ON) 5 g/ml doxycycline, from which indepen-
dent colonies were obtained for the mutation or recombination
analyses. Kar and Ura mutants were selected on SC contain-
ing 2% galactose and SC plus 5-fluoroorotic acid, respectively,
and Leu recombinants on SC-Leu plates. lacZ and lacZ were
distinguished by color on SC plus X-gal medium. Median
mutation and recombination frequencies were obtained by
fluctuation tests as the median value of six independent colonies
isolated from SC plates. The final frequency given for each strain
and condition is the mean and standard deviation of three to four
median values.
Miscellanea. Yeast methodology, -32P-labeled DNA probes, and
Southern and Northern blots were performed by following
standard procedures. GFP fluorescence was determined in a
FACSCalibur (Becton Dickinson, San Jose, CA) from 106 cells
grown in SC overnight and resuspended in 1 ml of H2O.
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